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Abstract 
Background: Diets enriched with n-3 polyunsaturated fatty acids (n-3 PUFAs) have been shown to 
exert a positive impact on muscle diseases. Flaxseed is one of the richest sources of n-3 PUFA acid 
α-linolenic acid (ALA). The aim of this study was to assess the effects of flaxseed and ALA in models of 
skeletal muscle degeneration characterized by high levels of Tumor Necrosis Factor-α (TNF). 
Methods: The in vivo studies were carried out on dystrophic hamsters affected by muscle damage 
associated with high TNF plasma levels and fed with a long-term 30% flaxseed-supplemented diet. 
Differentiating C2C12 myoblasts treated with TNF and challenged with ALA represented the in vitro 
model. Skeletal muscle morphology was scrutinized by applying the Principal Component Analysis 
statistical method. Apoptosis, inflammation and myogenesis were analyzed by immunofluorescence. 
Finally, an in silico analysis was carried out to predict the possible pathways underlying the effects of n-3 
PUFAs. 
Results: The flaxseed-enriched diet protected the dystrophic muscle from apoptosis and preserved 
muscle myogenesis by increasing the myogenin and alpha myosin heavy chain. Moreover, it restored the 
normal expression pattern of caveolin-3 thereby allowing protein retention at the sarcolemma. ALA 
reduced TNF-induced apoptosis in differentiating myoblasts and prevented the TNF-induced inhibition 
of myogenesis, as demonstrated by the increased expression of myogenin, myosin heavy chain and 
caveolin-3, while promoting myotube fusion. The in silico investigation revealed that FAK pathways may 
play a central role in the protective effects of ALA on myogenesis. 
Conclusions: These findings indicate that flaxseed may exert potent beneficial effects by preserving 
skeletal muscle regeneration and homeostasis partly through an ALA-mediated action. Thus, dietary 
flaxseed and ALA may serve as a useful strategy for treating patients with muscle dystrophies. 
Key words: muscle dystrophy; diet; flaxseed; Inflammation; myogenesis; in silico. 
Introduction 
Adult skeletal muscles represent a plastic organ 
endowed with a remarkable capacity to regenerate in 
response to injury [1]. The leading role in muscle 
growth and regeneration is played by satellite cells, 
which are anatomically positioned between the myo-
fiber sarcolemma and basal lamina [2] in quiescent 
conditions, and are rapidly activated to form new 
myofibers in response to appropriate stimuli [3]. In 
normal skeletal muscle, regeneration is a coordinated 
process in which several factors are sequentially acti-
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vated to maintain and preserve muscle structure and 
function. However, in some disease states, such as 
muscular dystrophy, this regenerative capacity is 
impaired [4, 5]. Dystrophies are hereditary skeletal 
muscle degenerative diseases caused by mutations in 
genes, most of which encode for proteins that are in-
dispensable to the integrity of the muscle cell mem-
brane and structure [6]. Their functional absence en-
hances muscle susceptibility to mechanical and bio-
chemical injuries, with consequent membrane leakage 
and loss of muscle cells [7]. Dystrophic muscle is 
characterized by progressive myofiber loss, chronic 
local inflammation and fibrosis, which in severe forms 
lead to paralysis, respiratory and cardiac failure and, 
eventually, the death of the patient. Indeed, the 
chronic inflammatory response creates a hostile mi-
croenvironment that inhibits the regenerative capacity 
of the satellite stem cells responsible for exacerbating 
the deleterious processes [4]. Therefore, modulation 
of the inflammatory signals in the muscle microenvi-
ronment represents a critical topic for current inves-
tigations. Nutritional factors may target critical play-
ers involved in inflammation response, tissue regen-
eration and repair [8]. Previous studies have demon-
strated that dietary flaxseed exerts an an-
ti-inflammatory effect in animals [9] and humans [10] 
by reducing circulating inflammatory molecules. 
Flaxseed is one of the richest sources of n3-PUFA acid 
α-linolenic acid (ALA) [11]. Our previous studies 
have demonstrated that dietary supplementation with 
flaxseed prevents the fibrosis and derangement of 
skeletal and cardiac muscle structure and function in 
dystrophic hamsters, markedly extending the ani-
mals’ lifespan [12-14]. In this animal model, charac-
terized by a deletion of the δ-sarcoglycan gene, muscle 
damage occurs early and peaks when the animal is 
120-150 days old. This late phase of disease is charac-
terized by increased plasma levels of tumor necrosis 
factor-α (TNF) [13]. TNF is a major pro-inflammatory 
cytokine that is expressed in damaged skeletal mus-
cle; increased TNF levels have been found in the 
plasma and muscles of dystrophic animals and hu-
mans [15]. High TNF plasma levels (0.5-10 ng/ml) 
have been associated with myoblast and myocyte 
apoptosis, inhibition of myogenic differentiation and 
muscle wasting [16-19]. Dietary flaxseed has been 
shown to counteract the deleterious effects of TNF on 
cardiac muscle cell survival through a mechanism 
that regulates caveolin-3 expression and accumulation 
in caveolae and is likely due to the ALA content of 
flaxseed [13]. Caveolin-3 is a muscle-specific protein 
involved in cardiac and skeletal muscle protection 
[20-22] and is essential for myoblast fusion and myo-
tube formation [23]. These findings suggest that flax-
seed and its n3 fatty acid ALA may be able to coun-
teract the harmful effects of TNF on myogenesis. 
Therefore, in the present study, we decided to inves-
tigate the possible beneficial effects of flaxseed and 
ALA in models of TNF-induced impaired myogenic 
differentiation. The in vivo model we adopted was the 
dystrophic hamster (Dystr/P), characterized by in-
creased TNF plasma levels associated with skeletal 
muscle degeneration, which was fed with a flax-
seed-enriched diet (FS diet) from weaning to death. 
Murine myoblasts treated with high concentrations of 
TNF and challenged with ALA represented the in vitro 
model. In addition, to identify the mechanisms and 
pathways underlying the effects of flaxseed and ALA 
on skeletal muscle, we carried out an in silico analysis. 
In view of the findings of previous studies that high-
lighted a possible epigenetic mechanism through 
which n-3 PUFAs regulate protein expression [24-26], 
we also performed an extensive literature search to 
identify putative microRNAs (miRNA) likely to un-
derlie the effects of n-3 PUFAs on impaired myogen-
esis.  
MicroRNAs (miRNAs) are 18–25 nucleotide 
non-coding RNAs that post-transcriptionally regulate 
gene expression by stalling the translation of the 
cognate mRNA or by promoting its degradation [27]. 
MicroRNAs are emerging as prominent players in 
myogenic differentiation [28] and represent a level of 
molecular regulation through which hundreds of 
genes involved in different signaling pathways can be 
regulated simultaneously [29]. Therefore, miRNAs 
can be used as a tool to uncover the pathways and 
targets that underlie changes in skeletal muscle in 
different pathophysiological conditions and after 
specific treatments. To identify the miRNA targets 
and pathways that are shared by more than one 
miRNA, a computer program named SID1.0 (simple 
String IDentifier) was developed [30]. This string 
identification program has proven to be a very useful 
tool to predict new genes, miRNAs and related targets 
and pathways involved in different pathophysiologi-
cal processes [30, 31]. In the present study, we per-
formed the in silico analysis of the pathways shared by 
different miRNAs involved in the effects of n-3 
PUFAs on myogenesis to support the experimental in 
vivo and in vitro observations.  
Materials and methods  
In Vivo 
Animals and Dietary Treatment 
Syrian hamsters (strain UM-X7.1), in which a 
deletion of the δ-sarcoglycan gene (δ-SG) determines a 
hereditary dystrophy that reproduces the human 
LGMD2F [32] phenotype, were used in the present 
study. Dystrophic hamsters were randomly divided 
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in 2 groups: the first group (Dystr/P group) was fed 
with standard pellet chow (Rieper SpA), the second 
group (Dystr/FS group) with a 30% flax-
seed-supplemented diet (FS diet). Golden Syrian 
hamsters bred under the same conditions and fed 
with standard pellet chow (P) were used as healthy 
controls (Healthy group). All animals were allowed to 
consume food ad libitum from weaning to sacrifice. 
The FS diet consisted of whole brown flaxseed, apples 
and carrots (30:50:20 w/w), with flaxseed (FS) being 
the only source of fats. The diet composition analysis, 
which was previously reported [14], showed that all 
macro- and micro-nutrients were quantitatively ade-
quate to maintain the animals healthy in both dietary 
regimens. This flaxseed diet has been recognized as 
source of n-3 PUFAs, with ALA representing 52% of 
the total lipids [11, 33] and is referred to throughout 
the paper as the FS diet. The average daily amount of 
flaxseed eaten by each animal was 2.1 g/day/100g 
body weight. The caloric power in 100 g of fresh Pellet 
or FS diet was 222.5±48 and 202.8±45 kcal, respec-
tively. Every 7 days, animal weights were recorded to 
exclude possible decreases attributable to calorie re-
striction. All the observations were made on 
150-day-old animals, i.e. an age when muscular dys-
function and degeneration is severe and clearly evi-
dent. 
Hamster Tissue Sampling 
The study protocol was preliminarily approved 
by the Animal Care Committee of the Tor Vergata 
University of Rome (Italy) and performed in accord-
ance with the Directive 2010/63/EU of the European 
Parliament. Hamsters were anesthetized with ure-
thane (400 mg/kg ip) and sacrificed at 150 days of 
age. Blood was collected by ventricular puncture, 
centrifuged and the plasma was stored at -80 °C until 
use. Biceps femoris muscles were rapidly excised, 
washed in cold PBS, frozen in liquid nitrogen and 
stored at -80°C until use. Alternatively, muscles were 
fixed with 4% paraformaldehyde and embedded in 
paraffin for microscopy analysis. At least 5 animals 
per group were considered for each analysis. 
Histological analysis  
Histological sections (4-μM) were cut from par-
affin-embedded skeletal muscles, deparaffinized in 
xylene, rehydrated in ethanol and stained with H&E 
(Bio-Optica, Milan, Italy) according to standard pro-
cedures in order to quantify the morphological ob-
servation. The images were acquired by means of a 
Leica DMRB microscope coupled with a digital cam-
era.  
To determine the percentage of myofibers with 
internalized nuclei, micrographs of H&E stained 
skeletal muscle sections were captured using a digital 
camera, and fibers with internalized nuclei were 
counted using NIH ImageJ software from five sections 
taken from each hamster (n=5 animals/group).  
Principal Component Analysis on histological section 
The images of H&E stained skeletal muscle sec-
tions (from six sections taken from each hamster, n=5 
animals/group) were processed by ImageJ software 
(http://imagej.nih.gov/ij/docs/intro.html). All the 
commands related to statistical measurements on 
image data, profile and histogram plotting and 
plugins related to image analysis can be found in 
http://imagej.nih.gov/ij/docs/guide/146-30.html#t
oc-Subsection-30.7. The following morphometric pa-
rameters were selected as being the most representa-
tive of fiber shape in the skeletal muscle: Area (area of 
selection in square pixels); Circ: (calculate to display 
circularity), AR (aspect ratio, major axis/minor axis); 
Round: (roundness); Solidity (area/convex area). 
Extracellular Area represents the extension of extra-
cellular matrix. Circ, AR and Round represent the 
shape descriptors.  
To detect any correlations between groups 
characterized by different morphologies, a principal 
components analysis (PCA) on the aforementioned 
morphometric parameters was carried out. The PCA 
is a procedure for analyzing multivariate data de-
signed to reduce the dimensionality of the data and 
allow the visualization of a large number of variables 
on a two-dimensional plot [34-36]. 
Three groups were considered in the in vivo ex-
periments, i.e. Healthy, Dystr/P and Dystr/FS, as 
well as six variables that correspond to the morpho-
logical parameters described above. A diagram of the 
values obtained from images for each group was 
plotted in bidimensional space, defined by the 1st and 
2nd Principal component functions on the x-axis and 
y-axis, respectively (PC1 and PC2). The variables 
correlated with the two principal components can be 
identified by the highest score coefficients in absolute 
values. A multivariate analysis of variance (ANOVA) 
was performed to compare the groups with regard to 
the variables extracted from the image analysis. 
Moreover, a univariate ANOVA test was applied for 
each variable, followed by a multiple comparison 
between the three groups performed by means of the 
least significance difference (LSD) test. The signifi-
cance level was set at alpha = 0.05. Statistical analyses 
were performed with SPSS 18.0. (Statistical Package 
for Social Sciences). For each PCA the variance ex-
plained by the model was evaluated [37].  
Tumor necrosis factor-alpha plasma levels 
Hamsters TNF plasma levels were measured 
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using a specific enzyme-linked immunosorbent assay 
(ELISA) (R&D Inc.), according to the manufacturer’s 
instructions. Values were from 6 animals/group. 
Apoptosis quantification 
TUNEL assay was performed on paraffin ham-
ster muscular sections using the terminal deoxynu-
cleotidyl transferase (TdT)-mediated in situ fluores-
cein-conjugated, dUTP nick end-labeling technique 
(In Situ Cell Death Detection Kit, Fluorescein), ac-
cording to the manufacturer’s protocol (Roche Diag-
nostic Corp.). Briefly, muscle sections (biceps femoris) 
were deparaffinized in xylene, rehydrated and then 
treated with proteinase-K before proceeding with the 
assay. Sections were stained with a mouse monoclo-
nal anti-α-sarcomeric-actin (Sigma-Aldrich) and then 
with anti-mouse Alexa 546 secondary antibodies 
(Molecular Probes). Nuclei were stained with DAPI. 
To determine the percentage of apoptotic cells, mi-
crographs of skeletal muscle sections were captured 
using a Leica microscope (Leica Microsystems 
DMRB), and positive and negative TUNEL nuclei 
were counted using NIH ImageJ software from five 
sections taken from each hamster (n=5-6 ani-
mals/group). 
Immunofluorescence  
Paraffin-embedded muscle sections were depar-
affinized in xylene, rehydrated, and then processed in 
10 mM citric acid (pH 6.0) by microwave for antigen 
retrieval treatment. The sections were then incubated 
in 8% BSA in PBS and stained with anti CD45, mono-
clonal (Santa Cruz), anti-alpha sarcomeric Actin, Pol-
yclonal, (Thermo Scientific Pierce), rabbit anti-Pax 
3–7, goat Mab ( Santa Cruz Biotechnology); an-
ti-myogenin, mouse Mab (BD Transduction), an-
ti-α-MHC, mouse Mab (from Stefano Schiaffino), 
rabbit polyclonal anti caveolin-3 (Abcam) followed by 
an appropriate secondary antibody: anti-mouse 546 
Alexa Fluor, anti-rabbit 546 Alexa Fluor, anti-rabbit 
488 Alexa Fluor and anti-goat 488 Alexa Fluor, (Mo-
lecular Probes). To label the sarcolemma, 
TRITC-Wheat germ agglutinin (TRITC-WGA, Sig-
ma-Aldrich) was dissolved in PBS and applied at a 
final concentration of 20 µg/ml for 1 h at room tem-
perature, after slide incubation with the secondary 
antibody. After nucleus staining with DAPI (Sig-
ma-Aldrich), skeletal muscle sections were analyzed 
by means of a fluorescence microscope (Leica Mi-
crosystems DMRB). All quantifications were per-
formed using ImageJ software 
(http://rsb.info.nih.gov/ij/). To determine the per-
centage of positive CD45 cells and positive Pax7 and 
myogenin nuclei, micrographs of skeletal muscle sec-
tions were captured and cells counted from six sec-
tions taken from each hamster, n=5 animals/group. 
To determine the fluorescence of α-MHC and caveo-
lin-3 levels in skeletal muscle sections, the total cell 
fluorescence (CTCF) was calculated from digital im-
ages using the following formula [38]: 
CTCF = Integrated Density - (Area of selected cell X 
Mean fluorescence of background readings) 
Images were from six sections, taken from each 
hamster ( n=6 animals/group).  
Northern Blot 
Total RNA was extracted from frozen skeletal 
muscle samples using TRIZol Reagent (Sig-
ma-Aldrich), according to the manufacturer’s speci-
fications, and an aliquot (20 µg) was electrophoresed 
on a 1.25% agarose gel containing 5% formaldehyde 
and transferred to Hybond N membrane (Amersham 
Corp., Arlington Heights, IL). Northern blot analysis 
of α-sarcomeric actin and myomesin was performed 
as previously described [14]; cDNA probes were 
kindly provided by Jean-Claude Perriard and Fabrizio 
Loreni. The Scion Image software was used to quan-
tify band intensity. 
In vitro 
Cell Cultures 
Murine C2C12 myoblasts (American Type Cul-
ture Collection) were cultured in growth media (GM) 
consisting of Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 15% Fetal Bovine Serum 
(FBS) and 50 mg/ml gentamicin (Sigma-Aldrich, St. 
Louis, MO) and seeded at a density of 104 cell/cm2 
onto multiwell plates or flasks. To induce differentia-
tion, when at 70% confluence, cells were shifted to a 
differentiating medium (DM) consisting of DMEM 
supplemented with 2% fetal horse serum and 50 
mg/ml gentamicin for 2 or 5 days. Cell cultures were 
treated with 10 ng/ml mouse recombinant TNF 
(Sigma-Aldrich) added to DM in order to mimic the in 
vivo inflammation environment for 2 or 5 days in the 
presence or absence of ALA. ALA was preliminarily 
complexed with fatty acid free bovine serum albumin 
(BSA fraction V, Sigma-Aldrich, fatty acid/BSA molar 
ratio 4:1) and added to DM at a concentration of 10 
µM. 
Principal Component Analysis on cell culture 
The morphometric parameters derived from 
light microscope images of H&E stained C2C12 cells 
were elaborated with the image processing software 
(ImageJ), as previously described for in vivo studies. 
The following morphometric parameters were con-
sidered: Area; StdDev (standard deviation of the gray 
values used to generate the mean gray value); X and Y 
Int. J. Med. Sci. 2016, Vol. 13 
 
http://www.medsci.org 
210 
Centroid (the average of the x and y coordinates of all 
of the pixels in the image or selection which uses the X 
and Y headings); XM and YM Center of Mass (the 
brightness-weighted average of the x and y coordi-
nates all pixels in the image or selection which uses 
the XM and YM headings); Perimeter (perimeter, the 
length of the outside boundary of the selection); the 
shape descriptors: AR; Round; Solidity; Circ; Num 
Nuclei (the number of nuclei in each cell). The rela-
tionship between groups characterized by different 
morphologies was assessed by PCA. In in vitro ex-
periments, four groups were considered: CTR/GM, 
CTR/DM, TNF and TNF ALA, together with the 
twelve variables that correspond to the morphological 
parameters described above. A diagram of the values 
obtained from images for each group was plotted in 
the bidimensional space, defined by the 1st and 2nd 
Principal components on the x-axis and y-axis, re-
spectively (PC1 and PC2). The variables correlated 
with the two principal components can be identified 
by the highest score coefficients in absolute values. A 
multivariate analysis of variance (ANOVA) was per-
formed to compare the groups with regard to the 
variables extracted from the image analysis. Moreo-
ver, a univariate ANOVA test was applied for each 
variable, followed by a multiple comparison between 
the three groups performed by using the least signif-
icance difference (LSD) test. The significance level was 
set at alpha = 0.05. Statistical analyses were performed 
with SPSS 18.0. (Statistical Package for Social Scienc-
es). The variance explained by the model was evalu-
ated for each PCA. 
Apoptosis quantification 
To analyze apoptotic nuclei by TUNEL assay, 
C2C12 cells were fixed in 4% paraformaldehyde in 
PBS, pH 7.4, and permeabilized with 0.1% Triton 
X-100 in 0.1% Na citrate. TUNEL assay was per-
formed using the terminal deoxynucleotidyl trans-
ferase (TdT)-mediated in situ fluorescein-conjugated, 
dUTP nick end-labeling technique (In Situ Cell Death 
Detection Kit, Fluorescein), according to the manu-
facturer’s protocol (Roche Diagnostic Corp.). To as-
sess cell apoptosis, nuclei were analyzed from 10 
random fields selected from 5 cell wells for each 
treatment using NIH ImageJ software. Apoptotic cell 
counts were expressed as the percentage of the total 
number of nuclei counted. 
Immunofluorescence 
Primary antibodies used for immunofluores-
cence were: monoclonal anti-myogenin mouse Mab 
(BD Transduction), MF20 monoclonal antibody 
(MAb) (Developmental Studies Hybridoma Bank, 
University of Iowa) and mouse anti-caveolin-3 (BD 
Transduction Laboratories™). Cells were fixed with 
4% paraformaldehyde and permeabilized with 0.1% 
Triton X-100 for 2 min and then incubated with pri-
mary antibody for 1 h and subsequently with an ap-
propriate secondary antibody (488 Alexa Fluor, Mo-
lecular Probes) for 1 h. After nucleus staining with 1 
µg/ml DAPI (Sigma-Aldrich), cells were analyzed 
using a fluorescence microscope (Leica Microsystems, 
Mod. DMRB) equipped with a digital camera. All 
quantifications were performed using ImageJ soft-
ware. (http://rsb.info.nih.gov/ij/). To determine the 
percentage of positive myogenin nuclei above the 
total number of nuclei, and MHC and caveolin-3 pos-
itive cells above the total number of cells, micrographs 
were captured and cells counted from a minimum of 
six random fields selected from three slides.  
The fusion index of C2C12 myoblasts after spe-
cific treatment was calculated as the average number 
of nuclei in MHC positive cells containing at least 
three nuclei above the total number of nuclei. 
Statistical analysis 
Results are expressed as the mean ± SD. The 
analysis of variance was performed (ANOVA) for 
comparisons between more than two groups, whereas 
the two-tailed unpaired Student’s t-test was used for 
comparisons of the mean differences between two 
groups. A suitable post-hoc test was used in combi-
nation with ANOVA to test for significant differences 
between groups. Differences were considered statis-
tically significant when P< 0.05. (SPSS for Windows, 
version 11.5; SPSS, Inc., Chicago, IL). 
In silico  
A literature search was performed using Pub-
Med or ISI Web of knowledge Databases to identify 
miRNAs with experimental evidence of involvement 
in murine muscle differentiation and modulated by 
n-3 PUFAs or TNF (last accessed December 21 2014). 
The following key words were used: miRNAs and 
differentiation and C2C12 or TNF and miRNAs or n-3 
PUFAs and miRNAs. Because a lack of data was 
found , regarding the influence of ALA on microRNA 
we extended PubMed searches to n-3 PUFAs. More-
over, we extended PubMed searches to humans 
miRNAs, because, (at the best of our knowledge) no 
literature on n-3 PUFAs modulation of miRNAs in 
murine cells was found as yet. Thus, the murine 
miRNAs, which are equivalent to humans mi-
croRNAs, were considered in the present research. To 
obtain the common pathways of specific miRNAs, the 
list IDs of KEGGs pathway and database 
DIANA-mirPath [39] were indexed using SID1.0. 
Since a visual inspection of the IDs would be unprac-
tical due to their large number (thousands IDs), they 
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have been automatically indexed using a simple 
Fortran written program (SID1.0; String IDentifier), 
developed by us [30], that looks for Refseq IDs shared 
by the predicted pathways of the different datasets. 
The database also allows to report the -ln(p-value) 
(the negative natural logarithm of the enrichment 
p-value calculated for the specific pathway). The 
p-value is a measure of the association between a se-
lected gene from the list of pathways. In pathway 
analysis, generally p-values less than 0.05 indicate 
that the association is not statistically significant and 
the pathway could be rejected. 
Results 
In Vivo 
Flaxseed diet improves the skeletal muscle architec-
ture in dystrophic hamsters 
Figure 1A shows haematoxylin/eosin staining of 
tissue sections from the hamster biceps femoris mus-
cles. The normal muscles display regular polygonal 
fibers, a homogeneous diameter and peripheral nuclei 
located directly below the sarcolemma. The Dystr/P 
muscle sections revealed fibers that were rounded in 
shape and of different sizes. In addition, an increased 
number of fibers with internalized nuclei were ob-
served, as quantified in Figure 1 B. Fibers under de-
generation were also observed. The FS diet resulted in 
an increased myofiber size, a reduced variability of 
myofiber size, and markedly decreased numbers of 
fibers with internalized nuclei and of degenerated 
fibers (Fig. 1 A, B). 
To quantify the effects of the FS diet on the 
morphology of the H&E staining skeletal muscle sec-
tions, the PCA [34] was performed. Six morphometric 
parameters were opportunely selected by ImageJ 
software, as reported in the Materials and Methods 
section (Fig. 1C). The measurements of these param-
eters were used as variables to construct two Principal 
component functions. The diagram of the values 
(Fig.1D) obtained from the morphometric parameters 
for each group (Healthy, Dystr/P and Dystr/FS) 
showed that the Principal component 1 (PC1) was 
strongly correlated with the Area, AR and solidity 
parameters; the Principal component 2 (PC2) was 
strongly correlated with the Circ, Round and Extra-
cellular Area parameters identified by the highest 
score coefficients in absolute values (Fig. 1C in the red 
box). Dystr/P (yellow dots) revealed a growing PC2 
(y-axis value) compared with the Healthy group (blue 
dots) (the total variance explained by the PC1 and PC2 
was 53.3 %) due to the round-shaped fibers and larger 
extracellular space (Fig. 1D). Despite being more dis-
persed than the other groups, the Dystr/FS group 
(green dots) clearly falls between the Dystr/P and 
Healthy groups. It is noteworthy that the morpho-
logical parameters of the muscles of hamsters fed with 
flaxseed (Dystr/FS) restored the Circ, Round and Ex-
tracellular Area parameters (PC2), thereby bringing 
these values closer to those of healthy animals and 
demonstrating the occurrence of larger myofibers 
(Fig. 1D). These results support the conclusion that 
the FS diet can significantly attenuate the histopatho-
logical features of dystrophy in hamster models of the 
disease. 
Flaxseed diet reduces inflammation and cell death 
In order to determine whether the altered mor-
phology in dystrophic skeletal muscles was associated 
with an inflammatory status, the level of plasma TNF 
in 150-days-old hamsters was investigated by ELISA 
analysis. TNF levels were markedly increased in 
plasma of Dystr/P (3.2 fold) vs. healthy controls (Fig. 
2A). The FS diet induced a slight, non-significant de-
crease in the cytokine levels. Inflammation of hamster 
muscle tissue was also monitored by pan-leukocyte 
marker CD45 immunofluorescence, which demon-
strated a marked increase in the number of inflam-
matory cells in the Dystr/P compared with the 
healthy muscle sections (Fig. 2B). By contrast, in the 
skeletal muscles of Dystr/FS, the number of CD45 
positive cells significantly decreased. Quantitative 
data are shown in Figure 2C. The high level of in-
flammation was associated with a higher number of 
apoptotic cells in the skeletal muscle of dystrophic 
hamsters than in those of healthy controls, as detected 
by TUNEL assay. The majority of the TUNEL-positive 
cells were located between the sarcolemma and the 
basal lamina (Fig. 2D). The FS diet significantly re-
duced the percentage of apoptotic cells in the Dystr/P 
to a level similar to that of healthy controls. The re-
duction in the number of inflammatory and apoptotic 
cells was associated with a general improvement in 
tissue texture, as demonstrated by co-staining with 
alpha-sarcomeric actin (Fig. 2D). The quantitative 
analysis of the TUNEL assay is shown in Figure 2E.  
Flaxseed diet improves myogenesis and differentiation 
In pellet-fed dystrophic vs. healthy hamster 
muscles, the aforementioned apoptosis was associat-
ed with a high expression of Pax7, a marker of satellite 
cells, as detected by immunofluorescence. Cells ex-
pressing Pax7, located between the sarcolemma and 
the basal lamina, were markedly reduced in flax-
seed-fed when compared with pellet-fed dystrophic 
hamsters (Fig. 3A). The quantification of the results is 
shown in Figure 3B. Conversely, myogenin-positive 
nuclei were increased in Dystr/FS when compared 
with Dystr/P muscles. (Fig. 3C). Quantitative data are 
shown in Figure 3D. 
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Figure 1. Flaxseed-enriched diet preserves dystrophic skeletal muscle morphology. For all in vivo observations, dystrophic hamsters were fed with a flax-
seed-enriched diet (FS) from weaning to the age of 150 days (Dystr/FS) and compared with dystrophic (Dystr/P) and healthy hamsters (Healthy) fed with standard 
pellet (P). (A) Representative images of H&E-stained skeletal muscle sections. Scale bar: 50 µm. (B) Percentage of myofibers with internalized nuclei from 
H&E-stained skeletal muscle sections. *P<0.05 vs. Healthy; § P<0.05 vs. Dystr/P; n=5. (C) Component Score Coefficient Matrix. The coefficients by which variables 
are multiplied to obtain factor scores are shown. The variables are represented by the morphometric parameters derived from light microscope images of skeletal 
muscle (six sections from each of 5 animals/group). The values highlighted (red boxes) indicate the variables most closely associated with Principal Components 1 and 
2. (D) Principal Component Analysis (PCA). Three series of data from of Healthy, Dystr/FS and Dystr/P hamsters were plotted in the bidimensional space defined by 
the 1st and 2nd PCA. FS diet (Dystr/FS, green dots) restored the morphological parameters of the dystrophic (Dystr/P, yellow dots) phenotype towards value closer 
to those of healthy (blue dots) skeletal muscles. 
 
 
Figure 2. Flaxseed diet precludes inflammation and apoptosis in dystrophic skeletal muscle. (A) Hamster TNF plasma levels. *P<0.05 vs. Healthy, n (number of 
animals per group)=6. (B) CD45 immunofluorescence (red) of skeletal muscle sections hamsters. α-sarcomeric actin staining (green) highlights the skeletal fibers; 
nuclei were stained with DAPI (blue); Scale bar: 10 µm. (C) Percentage of CD45 positive cells vs. total number of cells in the hamster skeletal muscles. *P<0.05 vs. 
Healthy; § P<0.001 vs. Dystr; n=5. (D) TUNEL assay of hamster skeletal muscle sections. Number of apoptotic nuclei (green) is higher in Dystr/P than in Healthy and 
Dystr/FS skeletal muscles. Muscle fibers are identified by α-sarcomeric actin expression (red); nuclei were stained with DAPI (blue). Scale bar: 30 µm. (E) Quantitative 
analysis of TUNEL-positive nuclei as a percentage of total DAPI-stained nuclei. *P<0.05 vs. Healthy; § P<0.05 vs. Dystr; n=5-6. 
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Figure 3. Flaxseed-enriched diet discontinues the negative degeneration/regeneration cycle in dystrophic skeletal muscle. (A) Pax7 immunofluorescence (green) of 
hamster skeletal muscle sections. Scale bar: 50 µm. Nuclei were stained with DAPI (Blue). (B) Bars represent the percentage of Pax7 positive cells of total 
DAPI-stained nuclei in hamster skeletal muscle sections. *P<0.05 vs. Healthy; § P<0.001 vs. Dystr/P; n=5. (C) Myogenin staining (red) in hamster skeletal muscle 
sections. Nuclei were stained with DAPI (Blue). Scale bar: 50 µm. (D) Histogram showing the percentage of myogenin-positive nuclei out of all DAPI-stained nuclei 
in hamster skeletal muscle sections. § P<0.05 vs. Dystr/P; n=5. (E) α-MHC immunofluorescence (red) of hamster skeletal muscle sections. Scale bar: 50 µm. (F) 
Quantification of α-MHC immunofluorescence (fiber/Area). Bars represent the average of total fluorescence intensity from each digital image calculated by ImageJ 
software. The values are expressed as a percentage of the healthy. *P<0.05 vs. Healthy; § P<0.05 vs. Dystr/P; n=6. (G) Representative images of caveolin-3 (green) and 
WGA-TRITC (sarcolemma marker, red) co-staining of hamster skeletal muscle sections. Merged images show that caveolin-3 expression increased in Dystr/FS vs. 
Dystr/P. The protein was mainly located in sarcolemma (yellow) in Healthy and Dystr/FS hamsters and in the cytosol in the Dystr/P animals, Scale bar: 20 µm. (H) 
Quantification of caveolin-3 immunofluorescence (fiber/Area). Bars represent the average of the total green fluorescence intensity from each digital image calculated 
by ImageJ software. The values are expressed as a percentage of the healthy. *P<0.05 vs. Healthy; § P<0.001 vs. Dystr/P; n=6. (I) The mRNA expression of 
α-sarcomeric actin and M-band marker myomesin in hamster skeletal muscle samples. Gapdh was used as an internal control. Band intensities are expressed as fold 
increases compared to those of healthy animals. 
 
To better understand the effects of the FS diet on 
muscle regenerative processes, we also tested the 
markers of advanced muscle differentiation, such as 
α-MHC and caveolin-3. Figures 3E and G show that 
α-MHC and caveolin-3 levels were up-regulated by 
the administration of flaxseed to dystrophic animals. 
The quantification of the expression of the α-MHC 
and caveolin-3 signals are reported in panels F and H 
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of Figure 3, respectively. In addition, caveolin-3 
(co-localized with WGA) was decreased in the sarco-
lemma of Dystr/P compared with healthy muscles. 
Flaxseed administration induced the correct caveo-
lin-3 localization within the sarcolemma in a fashion 
that was comparable to that of healthy hamster mus-
cles (Fig. 3G). In addition, Northern blot analysis re-
vealed higher amounts of α-sarcomeric actin and 
M-band marker myomesin, which points to the for-
mation of sarcomeres, in Dystr/FS than in Dystr/P 
muscles (Fig. 3I).  
In Vitro 
ALA preserves the morphology of differentiating 
myoblast C2C12 by attenuating the deleterious effects 
of TNF 
To test the effects of ALA on the inhibition in-
duced by TNF on myogenesis, murine C2C12 my-
oblasts were used as an in vitro cell model to recapit-
ulate myogenic differentiation. After 5 days in DM, 
TNF inhibited differentiation and myotube formation 
in C2C12 cells, as shown in the H&E stained image 
(Fig. 4A), thus confirming previous observations [40]. 
The addition of ALA to the DM prevented the inhib-
itory effect of TNF on myogenesis, thereby allowing 
the formation of myotubes in C2C12 cells. (Fig. 4 A).  
To quantify any morphological changes, the 
PCA analysis was elaborated from twelve morpho-
metric parameters opportunely selected and meas-
ured by ImageJ software. The resulting diagram (Fig. 
4C) demonstrated that the Principal component 1 
(PC1) was strongly associated with the Perim, AR, 
Circ, Num Nuclei, Area, Round and Solidity param-
eters, while the Principal component 2 (PC2) was 
strongly associated with StdDev, X, XM, Y and YM 
(red square in Fig. 4B). The PC1 varied markedly in 
differentiating (CTR/DM, green dots) and 
ALA-treated cells (TNF ALA, purple dots) when 
compared with the other groups (Fig. 4C).  
 
 
Figure 4. ALA preserves TNF-induced alterations on C2C12 cell morphology during differentiation. Cells cultured in differentiating medium (DM) were untreated 
(CTR-DM) or treated with TNF in the absence (TNF) or presence of α-linolenic acid (TNF ALA) for 5 days. Cells cultured in growth medium (CTR-GM) served as 
negative controls. (A) Hematoxylin and eosin (H&E) staining of C2C12 cells. Scale bar: 50 µm. (B) Component Score Coefficient Matrix. The coefficients by which 
variables are multiplied to obtain factor scores are shown. The variables are represented by the morphometric parameters derived from light microscope images of 
C2C12 cells. The values highlighted (red boxes) indicate the variables mostly closely associated with Principal Components 1 and 2. (C) Principal Component 
Analysis(PCA). The diagram shows the values from different experimental groups: CTR-GM, Blue dots; CTR-DM, green dots; TNF, yellow dots; TNF ALA, purple 
dots. The analysis indicates that the presence of ALA in the TNF-supplemented medium (TNF ALA) radically changed the morphological parameters of the C2C12 
phenotype, restoring values that approximated those of differentiated cells (CTR-DM). 
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The total variance explained by the PC1 and PC2 
was 64.6 %, which may be considered an excellent 
result. As shown in Figure 4C, the PC1 varied mark-
edly in untreated C2C12 cells grown in differentiating 
medium (CTR-DM, green dots) when compared with 
cells grown in GM (CTR-GM, blue dots). TNF in the 
DM (TNF, yellow dots) reduced the PC1, restoring 
morphological parameter values that approximated 
those of undifferentiated cells (CTR-GM). The addi-
tion of ALA in the medium (TNF ALA, purple dots) 
increased the PC1 and completely changed the mor-
phological parameter values of the C2C12 phenotype, 
restoring the Area, Perim, AR, Num Nuclei, Circ, 
Round and Solidity parameter values (associated with 
PC1) that approximated those of the CTR-DM fea-
tures. These results suggest that PCA analysis used 
for the quantification of morphological abnormalities 
in cellular and tissue of muscle disease models may be 
an excellent early predictor of such diseases.  
ALA reduces TNF-induced cell death and inhibition of 
differentiation on C2C12 cells 
To further investigate whether the ALA effects 
on myogenesis may be due to protection against my-
oblasts death, TUNEL analysis was carried out (Fig. 
5A). ALA reduced significantly the TNF-induced 
apoptosis in C2C12 cells, after 2 days in DM, as evi-
denced from the quantitative data reported in Fig. 5B. 
To test expression of differentiation markers, immu-
nofluorescence analysis was performed (Fig. 6). As 
expected, TNF inhibited C2C12 differentiation, after 5 
days in DM, decreasing the number of positive my-
ogenin nuclei and positive Myosin Heavy Chain 
(MHC) and caveolin-3 cells in respect to untreated 
cells (Fig. 6, A, C, F). ALA addition to DM restored the 
expression of myogenin, MHC and caveolin-3 in 
C2C12 cells after 5 days of treatment. (Fig. 6, A,C,F). 
In addition, ALA induced myoblast fusion that was 
significantly inhibited by TNF (Fig. 6 E). Quantitative 
data are reported in Fig. 6B, D, E and G. 
In Silico  
Predicted pathways affected by n-3 PUFAs 
One explanation for the experimental in vivo and 
in vitro results was hypothesized to be the involve-
ment of microRNAs. The following murine miRNAs 
associated with muscle differentiation were selected 
following a search in the literature: miR-23a, miR-24, 
miR-26a, miR-29a, miR-181a, miR-214 and miR-378, 
miR-1, miR-133 and miR-206 [41-52]. The search re-
vealed that four of the aforementioned murine mi-
croRNAs, i.e miR-206, miR-181a, miR-29a and 
miR-26a, involved in murine C2C12 muscle differen-
tiation are also modulated by n-3 PUFAs in human 
cells [25, 53]. These murine microRNAs, which are 
equivalent to human microRNAs, were therefore 
considered in the present research. In addition, the 
search in the literature highlighted that a further four 
miRNAs, i.e. miR-1, miR-133a, miR-133b and 
miR-206, involved in C2C12 cell differentiation are 
modulated by TNF in the same cells [54]. It is note-
worthy that miR-206 is modulated by both n-3 PUFAs 
and TNF. Therefore, the search in the literature 
yielded the following seven miRNAs for the compu-
tational analysis: miR-206, miR-181a, miR-29a, 
miR-26a, miR-1, miR-133a and miR-133b. The 
web-based computational database DIANA-MicroT 
3.0 was used to extract the KEGG pathway IDs po-
tentially altered by the expression of these seven 
miRNAs. These pathways were then filtered using the 
SID1.0 program to detect the common pathways. The 
database selected 149 common pathways (p-value 
range between 0.05 and 32.36). Table 1 shows all the 
common pathways with p values above 10 (13 com-
mon pathways). The common pathways selected in-
cluded those related to the cell-cell and cell-ECM in-
teraction, such as the FAK pathway and pathways 
related to communication between the external mi-
croenvironment and the interior of the cells (DNA), 
such as MAPK. 
Discussion 
Dystrophy is a disease that is characterized by 
progressive muscle degeneration and weakness with 
cycles of muscle necrosis and regeneration as its 
pathophysiological hallmarks [4, 5]. Although many 
therapeutic strategies have been proposed to coun-
teract dystrophy, clinically effective treatments are 
not yet available [55]. 
 
 
Table 1. Predict Pathways involved in the beneficial effects of n-3 
PUFAs on the impaired myogenesis 
KEGG Pathway Pathway ID -ln(p-value)  
Focal adhesion  mmu04510  32.36  
Adherens junction  mmu04520  15.1  
ECM-receptor interaction  mmu04512  14.96  
Axon guidance  mmu04360  14.43  
MAPK signaling pathway  mmu04010  13.9  
Glioma  mmu05214  13.78  
Regulation of actin cytoskeleton  mmu04810  13.23  
GnRH signaling pathway  mmu04912  12.65  
Chronic myeloid leukemia  mmu05220  12.49  
Renal cell carcinoma  mmu05211  11.09  
Long-term potentiation  mmu04720  11.09  
TGF-beta signaling pathway  mmu04350  10.1  
mTOR signaling pathway  mmu04150  10.08  
Common Pathways (Kegg pathway ID) of seven murine miRNAs involved in 
murine skeletal muscle differentiation: miR-206 (n-3 PUFAs and TNF modulated), 
miR-181a, miR-29a and miR-26a (n-3 PUFAs modulated) and miR-1, miR-133a and 
miR-133b ( TNF modulated). 
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Figure 5. ALA precludes TNF-induced apoptosis in differentiating C2C12 cells. Cells cultured in differentiating medium (DM) were untreated (CTR-DM) or treated 
with TNF in the absence (TNF) or presence of α-linolenic acid (TNF ALA) for 2 days. (A) TUNEL analysis of C2C12 cells. Nuclei were stained with DAPI (blue) and 
apoptotic nuclei were decorated in green. Scale bar: 10 μm. (B) Quantitative analysis of TUNEL-positive nuclei presented as a percentage of total DAPI-stained 
nuclei. * P<0.05 vs. CTR; § P<0.05 vs. TNF; n (number of cell wells with the same treatment)=5 
 
 
Figure 6. ALA induces muscle differentiation marker expression in differentiating C2C12 cells in the presence of TNF. Cells cultured in differentiating medium (DM) 
were untreated (CTR-DM) or treated with TNF in the absence (TNF) or presence of α-linolenic acid (TNF ALA) for 5 days. (A) Immunofluorescence detection of 
myogenin (green) in C2C12 cells. Scale bar: 50 µm. (B) Percentage of myogenin positive nuclei out of all DAPI-stained nuclei. *P<0.05 vs. CTR-DM; § P<0.05 vs. TNF; 
n=5. (C) Immunofluorescence detection of MHC (green) in C2C12 cells. Scale bar: 50 µm. (D) Percentage of MHC positive C2C12 cells out of all DAPI-stained 
nuclei. *P<0.05 vs. CTR-DM; §P<0.001 vs. TNF; n=5. (E) Fusion Index calculated as the average number of nuclei in MHC positive C2C12 cells containing at least three 
nuclei above the total number of nuclei. *P<0.05 vs. CTR-DM; § P<0.05 vs. TNF; n=5. (F) Immunofluorescence detection of caveolin-3 (green) in C2C12 cells. Scale 
bar: 30 µm. (G) Percentage of caveolin-3 positive cells out of all DAPI-stained nuclei. * P<0.05 vs. CTR-DM; § P<0.05 vs. TNF; n=5. In A, C and F nuclei were stained 
with DAPI (blue). 
 
The present investigation reveals that flaxseed 
exerts a significant protective effect against muscle 
damage induced by impaired tissue regeneration. 
Dystrophic hamsters, used in the present study as an 
in vivo model, displayed extensive muscle degenera-
tion at 150 days of age, when high levels of TNF and 
extensive tissue inflammation were reported [12, 13]. 
The FS diet mitigated the histological features of 
dystrophic skeletal muscles by preserving the differ-
entiated morphology of the myofibers. This finding 
was confirmed by the PCA analysis, a statistical tool 
used to predict the effectiveness of treatments, in both 
in vivo and in vitro experiments, by a direct and objec-
tive visualization of the morphological changes in a 
two-dimensional plot. Besides preserving the muscle 
tissue architecture, the FS diet restores the biochemi-
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cal expression pattern of myogenesis in dystrophic 
muscle. At least two mechanisms may account for the 
protective effects displayed by the FS diet on myo-
genesis: (i) an anti-apoptotic action on differentiating 
skeletal muscle cells and (ii) the regulation of the ex-
pression of key proteins involved in differentiation. 
Our results show that, in dystrophic muscles, the FS 
diet reduces the number of apoptotic nuclei, particu-
larly in interstitial cells, thus pointing to a possible 
protective effect on resident stem cells. Previous 
studies have reported that, although necrosis is 
probably the leading cause of myofiber degradation 
in many muscular dystrophies, apoptosis plays a 
paramount role in the depletion of satellite cells [56, 
57]. Thus, the suppression of myoblast apoptosis may 
be an important mechanism underlying the protective 
effects of FS on dystrophic muscles. In addition, the FS 
diet reduces the number of Pax7 positive cells in the 
dystrophic skeletal muscles while enhancing the 
number of cells expressing myogenesis markers, such 
as myogenin, α-MHC and caveolin-3. The FS diet thus 
appears to lead stem cell progression towards a dif-
ferentiating stage. The beneficial effects of the FS diet 
on dystrophic muscles are further supported by the 
observation that FS not only increases the quantity of 
caveolin-3, but also allows its retention at the sarco-
lemma. Caveolin-3, which is prerequisite for caveolae 
formation in striated muscles [58], plays a pivotal role 
in cardiac [59] and skeletal [22] muscle protection as 
well as in sarcolemma membrane repair [60]. In addi-
tion, it favors cell muscle differentiation through 
myoblast fusion and myotube formation [23]. Lastly, 
caveolin-3 binds to beta dystroglycan, thereby con-
tributing to the dystrophin-glycoprotein complex, 
which in turn links the cytoskeleton to the extracellu-
lar matrix [61]. The absence of the δ-sarcoglycan in 
dystrophic hamster muscles impairs the whole dys-
trophin-glycoprotein complex, which is indispensable 
to membrane integrity during muscle contraction, 
calcium homeostasis and survival signaling [7, 62]. 
Our previous studies have shown that the FS diet 
partly restores the expression pattern of the dystro-
phin-glycoprotein complex membrane proteins in 
dystrophic skeletal muscles [12]. Therefore, restora-
tion of the aberrant expression of caveolin-3 induced 
by the FS diet exerts a beneficial effect on the overall 
expression pattern of membrane signaling proteins in 
dystrophic muscles. 
These beneficial effects of FS diet may be due, at 
least in part, to the modulation of the inflammatory 
microenvironment of the dystrophic muscle, as 
demonstrated by the decreased number of CD45 cells. 
In keeping with this hypothesis, previous studies 
have reported an anti-inflammatory action of dietary 
flaxseed at the cellular and molecular levels that was 
attributed mainly to the ALA content of flaxseed [9, 
10]. It is noteworthy that plasma ALA levels increase 
significantly after ingestion of flaxseed in both hu-
mans [10, 63] and animals [9], including dystrophic 
hamsters [13]. ALA levels in the muscular tissue are 
also high in dystrophic hamsters on a flaxseed diet 
[12, 13]. 
TNF plasma levels were not, however, signifi-
cantly lowered by the FS diet in our study. Since TNF 
may induce a bimodal myogenic response in muscle 
cells depending on its concentration, ALA may be 
hypothesized to change TNF signaling. Indeed, in 
previous studies, pathological levels of TNF have 
been associated with skeletal muscle apoptosis and 
inhibition of differentiation [16, 17, 64], while cytokine 
physiological concentrations have been reported to 
activate myogenesis [65].  
The in vitro experiments we performed une-
quivocally revealed a direct effect of ALA on differ-
entiating myoblasts. ALA reduced apoptosis in dif-
ferentiating myoblasts even in the presence of high 
concentrations of TNF. In addition, ALA prevented 
the TNF-induced inhibition of myogenesis, as 
demonstrated by the increased expression of myog-
enin, MHC and caveolin-3 in C2C12 cells, while pro-
moting myotube fusion. Therefore, ALA may modu-
late the dichotomy of TNF signalling properties that 
favor myogenesis and the survival signal pathways as 
opposed to the apoptotic pathways.  
Taken together, our in vivo and in vitro results 
show that, besides reducing fibrosis and improving 
muscle structure of dystrophic hamsters [12], the FS 
diet enhances the survival of myoblasts and preserves 
their differentiation, probably owing to an 
ALA-mediated action. The FS diet consequently re-
verts the myocyte degeneration that is typical of dys-
trophic muscles. The upstream mechanisms of these 
effects may be due to: (i) the incorporation of ALA 
into the membrane and the subsequent alteration of 
the location of the TNF receptor domains in the cave-
olae/non-caveolae lipid regions of muscle cell mem-
branes or (ii) an epigenetic effect on the transcription 
of genes for proteins involved in cell muscle protec-
tion and differentiation, such as caveolin-3. Since n-3 
PUFAs may act through epigenetic mechanisms [25, 
66] and miRNAs play an important role in myogene-
sis [28], it may be speculated that miRNA expression 
is modulated by n3 fatty acid ALA. An in silico analy-
sis on a total of seven microRNAs, selected from a 
search in the literature, uncovered the possible altered 
signal pathways involved in the effects exerted by n-3 
PUFAs on myogenesis. 
The in silico analysis suggests that the focal ad-
hesion kinase (FAK) pathway that exhibits the highest 
p value (32.36) may play a central role in the regula-
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tion of myogenesis by ALA. The FAK pathway regu-
lates cellular processes such as migration, growth, 
survival and differentiation [67]. In skeletal muscle, 
FAK signaling has been shown to regulate the ex-
pression of caveolin-3 and β1 integrin, two genes that 
are essential for myoblast fusion [68]. Therefore, ALA 
may indirectly regulate caveolin-3 expression through 
the FAK pathway. Since FAK is at the intersection of 
many signaling pathways, it is likely to regulate my-
ogenesis by targeting multiple pathways. Pathways 
that are linked to communications between the ex-
ternal microenvironment and the interior of the cells 
(DNA), such as MAPK, may also be involved. Lastly, 
pathways, such as mTOR, which are involved in the 
balance between hypertrophy-atrophy/survival- 
death in skeletal muscle and mediate cellular re-
sponses to nutrients [69], may play an important role 
in orchestrating the beneficial effects of ALA on skel-
etal muscle. Indeed, the activation of both the p38 
MAPK and PI3-kinase/Akt/mTOR pathways is re-
quired for proper caveolin-3 up-regulation during 
muscle differentiation [70]. Although each in silico 
prediction will need to be validated experimentally, 
these results provide a good starting point for future 
investigations into the role of n-3 PUFAs in the regu-
lation of myogenesis. 
In conclusion, the present study demonstrates 
that the pathological status of muscular dystrophy 
can be effectively mitigated by administering natural 
compounds contained in flaxseed that have a plei-
otropic effect rather than by targeting a specific gene 
mutation as occurs in other therapeutic strategies [71]. 
Although the beneficial effects appear to be due above 
all to the ALA component of flaxseed, as is suggested 
by vitro experiments, the possible involvement of 
other flaxseed components that induce or enhance 
those effects, such as lignans and fibers, cannot be 
ruled out and warrant further investigation. Taken 
together, our findings suggest that flaxseed not only 
repairs the damage in the sarcolemma, which is the 
primary consequence of gene mutation, but also ex-
erts a more extensive epigenetic action that stimulates 
multiple molecular pathways in dystrophic muscles.  
The prolonged exposure of dystrophic muscles 
(from weaning to death) to flaxseed components such 
as ALA would presumably allow a constant modula-
tion of the muscle microenvironment that would, in 
turn, effectively alleviate muscle damage. Thus, ad-
ministration of flaxseed and ALA to patients with 
muscular dystrophies may be beneficial in the clinical 
setting 
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